FFA
BLUE

Freedman Financial Associates’s bluebird bio BLUE Stock Holding History

Freedman Financial Associates’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25
Closed -$3K – 49
2022
Q1 		$3K Hold
25
– – ﹤0.01% 434
2021
Q4 		$5K Sell
25
-14
-36% -$3.3K ﹤0.01% 383
2021
Q3 		$10K Hold
39
– – 0.01% 345
2021
Q2 		$16K Hold
39
– – 0.01% 310
2021
Q1 		$15K Hold
39
– – 0.01% 322
2020
Q4 		$22K Buy
+39
New +$24.7K 0.02% 284

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Freedman Financial Associates's BLUE Position: Q2 2022 in Review

Freedman Financial Associates sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 25 shares — an estimated $3K sold.

Freedman Financial Associates first reported a position in BLUE in Q4 2020 and held it in 6 quarters. The position peaked at $22K in Q4 2020. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

  • Freedman Financial Associates reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 25 bluebird bio shares in Q2 2022, an estimated $3K.
  • Freedman Financial Associates first reported a position in bluebird bio in Q4 2020 and held it in 6 quarters.
  • Freedman Financial Associates's bluebird bio position peaked at $22K in Q4 2020.
  • 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.